论文部分内容阅读
原发性肝癌(PHC)是临床上常见的恶性肿瘤之一,甲胎蛋白(AFP)是诊断PHC的重要肿瘤标志物,但其敏感性较低。近年来,联合检测多种肿瘤标志物以提高对PHC诊断的敏感性引起广泛关注。本研究旨在探讨联合检测Survivin、AFP对诊断PHC的临床意义。
Primary liver cancer (PHC) is one of the most common clinical malignancies. AFP is an important tumor marker for PHC diagnosis, but its sensitivity is low. In recent years, the joint detection of a variety of tumor markers to improve the sensitivity of PHC diagnosis caused widespread concern. This study aimed to explore the clinical significance of combined detection of Survivin and AFP in the diagnosis of PHC.